Metraipolis › archive › dc_127c6ca3abba

Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy — Europe PMC PMID:41754865

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41754865
DOI
10.3390/ph19020324
License (as archived)
solo-consultazione
Archived
2026-11-05T19:25:57.655Z
SHA-256 of the archived text
2aec34728389aba299c92b91563b65ae7338fb758325f864ea26a3cbd62b738f
Stable URL of this page
https://metraipolis.com/documento/dc_127c6ca3abba

How to cite

Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy — Europe PMC PMID:41754865 — Europe PMC (en), https://europepmc.org/article/MED/41754865 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_127c6ca3abba (Metraipolis archive dc_127c6ca3abba, sha256 2aec34728389aba299c92b91563b65ae7338fb758325f864ea26a3cbd62b738f)
BibTeX
@misc{dc127c6ca3abba,
  title = {Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy — Europe PMC PMID:41754865},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41754865},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_127c6ca3abba; sha256 2aec34728389aba299c92b91563b65ae7338fb758325f864ea26a3cbd62b738f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41754865. Agents can read the archived copy with the MCP tool read_document.